Protective effect of leukemia inhibitory factor on the retinal injury induced by acute ocular hypertension in rats

Lv,Jiexuan; Gao,Ruxin; Wang,Yao; Huang,Changquan; Wu,Renyi

doi:10.3892/etm.2022.11717

Protective effect of leukemia inhibitory factor on the retinal injury induced by acute ocular hypertension in rats

Authors:
- Jiexuan Lv
- Ruxin Gao
- Yao Wang
- Changquan Huang
- Renyi Wu
View Affiliations

Affiliations: Eye Institute and Affiliated Xiamen Eye Center of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361001, P.R. China, Shaanxi Provincial Key Laboratory of Ophthalmology, Shaanxi Institute of Ophthalmology, Shaanxi Clinical Study Center for Ocular Disease, The First Affiliated Hospital of Xi'an Jiaotong University, Medical School, Northwest University, Xi'an, Shaanxi 710002, P.R. China
Published online on: November 22, 2022 https://doi.org/10.3892/etm.2022.11717
Article Number: 19
Copyright: © Lv et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glaucoma is one of the leading causes of irreversible blindness worldwide. As such, neuroprotective therapy is essential for the treatment of this disease. Leukemia inhibitory factor (LIF) is a member of the IL‑6 cytokine family and the LIF signaling pathway is considered to be one of the major endogenous factors mediating neuroprotection in the retina. Therefore, the present study aimed to investigate the possible effects of LIF in acute ocular hypertension (AOH). The intraocular pressure in rat eyes was raised to 110 mmHg for 1 h by infusing the anterior chamber with normal saline to establish the AOH model. In the treatment group, LIF was then injected into the vitreous cavity after AOH was ceased. The retinal tissues were obtained after the termination of AOH, and H&E staining was conducted to assess the morphological damage. The number of retinal ganglion cells (RGCs) was counted using the Fluoro‑Gold retrograde staining method. TUNEL staining was used to determine the extent of apoptosis among the retinal cells. In addition, the protein expression levels of cleaved caspase‑3, poly (ADP‑ribose) polymerase (PARP), STAT3 and components of the AKT/mTOR/70‑kDa ribosomal protein S6 kinase (p70S6K) signaling pathway were examined by western blotting. The results showed that AOH induced tissue swelling and structural damage in the retina, which were reversed by LIF injection. In the LIF treatment group, RGC loss was significantly inhibited and the quantity of TUNEL‑stained cells was also significantly reduced, whereas the expression of cleaved caspase‑3 and PARP was decreased. Furthermore, increased phosphorylation of STAT3, AKT, mTOR and p70S6K was observed after LIF treatment. By contrast, pretreatment with the STAT3 inhibitor C188‑9 or the PI3K/AKT/mTOR inhibitor LY3023414 reversed the LIF‑induced inhibition of RGC loss. These results suggested that exogenous LIF treatment inhibited the retinal damage induced by AOH, which was associated with the activation of STAT3 and mTOR/p70S6K signaling. Therefore, LIF may serve a role in neuroprotection for glaucoma treatment.

View Figures

View References

1	Tham YC, Li X, Wong TY, Quigley HA, Aung T and Cheng CY: Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology. 121:2081–2090. 2014.PubMed/NCBI View Article : Google Scholar
2	Quigley HA: Glaucoma. Lancet. 377:1367–1377. 2011.PubMed/NCBI View Article : Google Scholar
3	Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B and Hussein M: Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial. Arch Ophthalmol. 120:1268–1279. 2002.PubMed/NCBI View Article : Google Scholar
4	Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA and Mills RP: CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 108:1943–1953. 2001.PubMed/NCBI View Article : Google Scholar
5	Leske MC, Heijl A, Hyman L, Bengtsson B and Komaroff E: Factors for progression and glaucoma treatment: The Early Manifest Glaucoma Trial. Curr Opin Ophthalmol. 15:102–106. 2004.PubMed/NCBI View Article : Google Scholar
6	Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 126:487–497. 1998.PubMed/NCBI View Article : Google Scholar
7	Diekmann H and Fischer D: Glaucoma and optic nerve repair. Cell Tissue Res. 353:327–337. 2013.PubMed/NCBI View Article : Google Scholar
8	Gauthier AC and Liu J: Neurodegeneration and neuroprotection in glaucoma. Yale J Biol Med. 89:73–79. 2016.PubMed/NCBI
9	He S, Stankowska DL, Ellis DZ, Krishnamoorthy RR and Yorio T: Targets of neuroprotection in glaucoma. J Ocul Pharmacol Ther. 34:85–106. 2018.PubMed/NCBI View Article : Google Scholar
10	Wang Y, Lv J, Huang C, Li X, Chen Y, Wu W and Wu R: Human Umbilical Cord-mesenchymal stem cells survive and migrate within the vitreous cavity and ameliorate retinal damage in a novel rat model of chronic glaucoma. Stem Cells Int. 2021(8852517)2021.PubMed/NCBI View Article : Google Scholar
11	Büchi ER: Cell death in rat retina after pressure-induced ischaemia-reperfusion insult: Electron microscopic study. II. Outer nuclear layer. Jpn J Ophthalmol. 36:62–68. 1992.PubMed/NCBI
12	Büchi ER: Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: An electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp Eye Res. 55:605–613. 1992.PubMed/NCBI View Article : Google Scholar
13	Burgoyne CF, Downs JC, Bellezza AJ, Suh JK and Hart RT: The optic nerve head as a biomechanical structure: A new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res. 24:39–73. 2005.PubMed/NCBI View Article : Google Scholar
14	Fechtner RD and Weinreb RN: Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol. 39:23–42. 1994.PubMed/NCBI View Article : Google Scholar
15	Fahy ET, Chrysostomou V and Crowston JG: Mini-review: Impaired axonal transport and glaucoma. Curr Eye Res. 41:273–283. 2016.PubMed/NCBI View Article : Google Scholar
16	Hartsock MJ, Cho H, Wu L, Chen WJ, Gong J and Duh EJ: A Mouse model of retinal ischemia-reperfusion injury through elevation of intraocular pressure. J Vis Exp. 54065:2016.PubMed/NCBI View Article : Google Scholar : doi: 10.3791/54065.
17	Osborne NN, Ugarte M, Chao M, Chidlow G, Bae JH, Wood JP and Nash MS: Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 43 (Suppl 1):S102–S128. 1999.PubMed/NCBI View Article : Google Scholar
18	Faiq MA, Wollstein G, Schuman JS and Chan KC: Cholinergic nervous system and glaucoma: From basic science to clinical applications. Prog Retin Eye Res. 72(100767)2019.PubMed/NCBI View Article : Google Scholar
19	Adornetto A, Russo R and Parisi V: Neuroinflammation as a target for glaucoma therapy. Neural Regen Res. 14:391–394. 2019.PubMed/NCBI View Article : Google Scholar
20	Joly S, Lange C, Thiersch M, Samardzija M and Grimm C: Leukemia inhibitory factor extends the lifespan of injured photoreceptors in vivo. J Neurosci. 28:13765–13774. 2008.PubMed/NCBI View Article : Google Scholar
21	Leibinger M, Müller A, Andreadaki A, Hauk TG, Kirsch M and Fischer D: Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. J Neurosci. 29:14334–14341. 2009.PubMed/NCBI View Article : Google Scholar
22	Burdon T, Smith A and Savatier P: Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12:432–438. 2002.PubMed/NCBI View Article : Google Scholar
23	Mathieu ME, Saucourt C, Mournetas V, Gauthereau X, Thézé N, Praloran V, Thiébaud P and Bœuf H: LIF-dependent signaling: New pieces in the Lego. Stem Cell Rev Rep. 8:1–15. 2012.PubMed/NCBI View Article : Google Scholar
24	Peñuelas S, Anido J, Prieto-Sánchez RM, Folch G, Barba I, Cuartas I, García-Dorado D, Poca MA, Sahuquillo J, Baselga J and Seoane J: TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell. 15:315–327. 2009.PubMed/NCBI View Article : Google Scholar
25	Pera MF and Tam PP: Extrinsic regulation of pluripotent stem cells. Nature. 465:713–720. 2010.PubMed/NCBI View Article : Google Scholar
26	Zeng X, Huang Z, Mao X, Wang J, Wu G and Qiao S: N-carbamylglutamate enhances pregnancy outcome in rats through activation of the PI3K/PKB/mTOR signaling pathway. PLoS One. 7(e41192)2012.PubMed/NCBI View Article : Google Scholar
27	Zouein FA, Kurdi M and Booz GW: LIF and the heart: Just another brick in the wall? Eur Cytokine Netw. 24:11–19. 2013.PubMed/NCBI View Article : Google Scholar
28	Rattner A and Nathans J: The genomic response to retinal disease and injury: Evidence for endothelin signaling from photoreceptors to glia. J Neurosci. 25:4540–4549. 2005.PubMed/NCBI View Article : Google Scholar
29	Samardzija M, Wariwoda H, Imsand C, Huber P, Heynen SR, Gubler A and Grimm C: Activation of survival pathways in the degenerating retina of rd10 mice. Exp Eye Res. 99:17–26. 2012.PubMed/NCBI View Article : Google Scholar
30	Samardzija M, Wenzel A, Aufenberg S, Thiersch M, Remé C and Grimm C: Differential role of Jak-STAT signaling in retinal degenerations. Faseb J. 20:2411–2413. 2006.PubMed/NCBI View Article : Google Scholar
31	Schaeferhoff K, Michalakis S, Tanimoto N, Fischer MD, Becirovic E, Beck SC, Huber G, Rieger N, Riess O, Wissinger B, et al: Induction of STAT3-related genes in fast degenerating cone photoreceptors of cpfl1 mice. Cell Mol Life Sci. 67:3173–3186. 2010.PubMed/NCBI View Article : Google Scholar
32	Agca C and Grimm C: Leukemia inhibitory factor signaling in degenerating retinas. Adv Exp Med Biol. 801:389–394. 2014.PubMed/NCBI View Article : Google Scholar
33	Liu SC, Tsang NM, Chiang WC, Chang KP, Hsueh C, Liang Y, Juang JL, Chow KP and Chang YS: Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest. 123:5269–5283. 2013.PubMed/NCBI View Article : Google Scholar
34	Chen H, Qu Y, Tang B, Xiong T and Mu D: Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: Potential neuroprotection and limitations. Rev Neurosci. 23:279–287. 2012.PubMed/NCBI View Article : Google Scholar
35	Hu Q, Huang C, Wang Y and Wu R: Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension. Mol Med Rep. 12:6577–6583. 2015.PubMed/NCBI View Article : Google Scholar
36	Xu J, Li Y, Song S, Cepurna W, Morrison J and Wang RK: Evaluating changes of blood flow in retina, choroid, and outer choroid in rats in response to elevated intraocular pressure by 1300 nm swept-source OCT. Microvasc Res. 121:37–45. 2019.PubMed/NCBI View Article : Google Scholar
37	Lafuente MP, Villegas-Pérez MP, Sellés-Navarro I, Mayor-Torroglosa S, Miralles de Imperial J and Vidal-Sanz M: Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience. 109:157–168. 2002.PubMed/NCBI View Article : Google Scholar
38	Liao XX, Chen D, Shi J, Sun YQ, Sun SJ, So KF and Fu QL: The expression patterns of Nogo-A, myelin associated glycoprotein and oligodendrocyte myelin glycoprotein in the retina after ocular hypertension: The expression of myelin proteins in the retina in glaucoma. Neurochem Res. 36:1955–1961. 2011.PubMed/NCBI View Article : Google Scholar
39	Ueki Y, Wang J, Chollangi S and Ash JD: STAT3 activation in photoreceptors by leukemia inhibitory factor is associated with protection from light damage. J Neurochem. 105:784–796. 2008.PubMed/NCBI View Article : Google Scholar
40	Majumder A, Banerjee S, Harrill JA, Machacek DW, Mohamad O, Bacanamwo M, Mundy WR, Wei L, Dhara SK and Stice SL: Neurotrophic effects of leukemia inhibitory factor on neural cells derived from human embryonic stem cells. Stem Cells. 30:2387–2399. 2012.PubMed/NCBI View Article : Google Scholar
41	Crowley LC and Waterhouse NJ: Detecting cleaved Caspase-3 in apoptotic cells by flow cytometry. Cold Spring Harb Protoc. (2016)2016.PubMed/NCBI View Article : Google Scholar
42	Soldani C and Scovassi AI: Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update. Apoptosis. 7:321–328. 2002.PubMed/NCBI View Article : Google Scholar
43	Seki M and Lipton SA: Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog Brain Res. 173:495–510. 2008.PubMed/NCBI View Article : Google Scholar
44	Lee HJ, Lee JO, Lee YW, Kim SA, Seo IH, Han JA, Kang MJ, Kim SJ, Cho YH, Park JJ, et al: LIF, a novel myokine, protects against amyloid-beta-induced neurotoxicity via akt-mediated autophagy signaling in hippocampal cells. Int J Neuropsychopharmacol. 22:402–414. 2019.PubMed/NCBI View Article : Google Scholar
45	Bürgi S, Samardzija M and Grimm C: Endogenous leukemia inhibitory factor protects photoreceptor cells against light-induced degeneration. Mol Vis. 15:1631–1637. 2009.PubMed/NCBI
46	Morgan-Warren PJ, Berry M, Ahmed Z, Scott RA and Logan A: Exploiting mTOR signaling: A novel translatable treatment strategy for traumatic optic neuropathy? Invest Ophthalmol Vis Sci. 54:6903–6916. 2013.PubMed/NCBI View Article : Google Scholar